MX2018008809A - Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv. - Google Patents
Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv.Info
- Publication number
- MX2018008809A MX2018008809A MX2018008809A MX2018008809A MX2018008809A MX 2018008809 A MX2018008809 A MX 2018008809A MX 2018008809 A MX2018008809 A MX 2018008809A MX 2018008809 A MX2018008809 A MX 2018008809A MX 2018008809 A MX2018008809 A MX 2018008809A
- Authority
- MX
- Mexico
- Prior art keywords
- adv
- monoclonal antibodies
- infection
- useful
- seq
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención se refiere a anticuerpos monoclonales, o fragmentos de los mismos, que reconocen la proteína pIII del Adenovirus (ADV), útiles para el desarrollo de métodos de diagnóstico de infección por ADV en humanos. En particular se refiere a un anticuerpo monoclonal o un fragmento de él que comprende una región variable de la cadena pesada que tiene una secuencia con al menos un 90%, 95% o 99% de identidad con la SEQ ID No: 1 o SEQ ID No: 5 y una región variable de la cadena liviana que tiene una secuencia con al menos un 90%, 95% o 99% de identidad con la SEQ ID No: 2 o SEQ ID No: 6. También se dirige a las secuencias nucleotídicas que definen dichos anticuerpos, métodos in vitro y/o ex vivo de diagnóstico de infección por ADV en una muestra biológica que utilizan dichos anticuerpos monoclonales, y kits de diagnóstico para detectar ADV, que comprenden al menos un anticuerpo monoclonal contra ADV de acuerdo a lo descrito anteriormente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2016000164A CL2016000164A1 (es) | 2016-01-21 | 2016-01-21 | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv. |
PCT/IB2017/050312 WO2017125892A2 (es) | 2016-01-21 | 2017-01-20 | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018008809A true MX2018008809A (es) | 2018-11-29 |
Family
ID=56610130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018008809A MX2018008809A (es) | 2016-01-21 | 2017-01-20 | Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv. |
Country Status (14)
Country | Link |
---|---|
US (1) | US10766948B2 (es) |
EP (2) | EP3406262B1 (es) |
CN (1) | CN108697796B (es) |
AR (1) | AR107440A1 (es) |
BR (1) | BR112018014538A2 (es) |
CA (1) | CA3011569A1 (es) |
CL (1) | CL2016000164A1 (es) |
ES (1) | ES2898068T3 (es) |
MX (1) | MX2018008809A (es) |
PE (1) | PE20181498A1 (es) |
PT (1) | PT3406262T (es) |
UY (1) | UY37082A (es) |
WO (1) | WO2017125892A2 (es) |
ZA (1) | ZA201804705B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2018003869A1 (es) * | 2018-12-28 | 2021-01-15 | Univ Pontificia Catolica Chile | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv |
CN113354727B (zh) * | 2021-08-10 | 2021-11-02 | 北京溯本源和生物科技有限公司 | 一组同时检测b/c/e组腺病毒的单克隆抗体和试纸条 |
CN118027181A (zh) * | 2023-06-14 | 2024-05-14 | 珠海重链生物科技有限公司 | 六邻体蛋白抗体及其应用 |
CN117586385B (zh) * | 2023-11-23 | 2024-05-17 | 广州医科大学附属第一医院(广州呼吸中心) | 抗人4型腺病毒中和抗体及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4487829A (en) | 1982-03-23 | 1984-12-11 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies against adenoviruses |
US6248514B1 (en) * | 1996-07-09 | 2001-06-19 | Canji, Inc. | Methods for measuring viral infectivity |
CN1207569C (zh) | 1997-08-04 | 2005-06-22 | 株式会社先端生命科学研究所 | 用于测定含病毒样品的方法、病毒测定方法和诊断试剂盒 |
AU2001277531A1 (en) * | 2000-07-10 | 2002-01-21 | Novartis Ag | Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
WO2005023848A2 (en) * | 2003-09-09 | 2005-03-17 | Gardner, Rebecca, Katherine | Adenoviral epitopes |
CA2548942C (en) * | 2003-12-05 | 2013-10-15 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health | Anti-sars monoclonal antibodies |
US8003108B2 (en) * | 2005-05-03 | 2011-08-23 | Amgen Inc. | Sclerostin epitopes |
GB2462048B (en) * | 2007-05-03 | 2012-03-21 | Agency Science Tech & Res | Antibodies binding to an intracellular prl-1 or prl-3 polypeptide |
-
2016
- 2016-01-21 CL CL2016000164A patent/CL2016000164A1/es unknown
-
2017
- 2017-01-20 US US16/070,730 patent/US10766948B2/en active Active
- 2017-01-20 CN CN201780007470.2A patent/CN108697796B/zh active Active
- 2017-01-20 MX MX2018008809A patent/MX2018008809A/es unknown
- 2017-01-20 EP EP17741167.5A patent/EP3406262B1/en active Active
- 2017-01-20 BR BR112018014538-6A patent/BR112018014538A2/pt unknown
- 2017-01-20 WO PCT/IB2017/050312 patent/WO2017125892A2/es active Application Filing
- 2017-01-20 UY UY0001037082A patent/UY37082A/es not_active Application Discontinuation
- 2017-01-20 CA CA3011569A patent/CA3011569A1/en active Pending
- 2017-01-20 ES ES17741167T patent/ES2898068T3/es active Active
- 2017-01-20 PT PT177411675T patent/PT3406262T/pt unknown
- 2017-01-20 PE PE2018001294A patent/PE20181498A1/es unknown
- 2017-01-20 EP EP20166433.1A patent/EP3756685A1/en active Pending
- 2017-01-20 AR ARP170100158A patent/AR107440A1/es unknown
-
2018
- 2018-07-13 ZA ZA2018/04705A patent/ZA201804705B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR107440A1 (es) | 2018-05-02 |
PT3406262T (pt) | 2021-11-03 |
UY37082A (es) | 2017-04-28 |
BR112018014538A2 (pt) | 2018-12-26 |
US20190048065A1 (en) | 2019-02-14 |
CN108697796B (zh) | 2023-01-10 |
EP3406262B1 (en) | 2021-07-28 |
WO2017125892A2 (es) | 2017-07-27 |
ES2898068T3 (es) | 2022-03-03 |
CN108697796A (zh) | 2018-10-23 |
CA3011569A1 (en) | 2017-07-27 |
EP3406262A2 (en) | 2018-11-28 |
WO2017125892A3 (es) | 2018-04-12 |
EP3406262A4 (en) | 2019-01-09 |
CL2016000164A1 (es) | 2016-07-29 |
ZA201804705B (en) | 2019-09-25 |
PE20181498A1 (es) | 2018-09-18 |
EP3756685A1 (en) | 2020-12-30 |
US10766948B2 (en) | 2020-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018008809A (es) | Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv. | |
ES2563955T3 (es) | Método para identificar linfocitos T reguladores | |
JP2017518366A5 (es) | ||
PE20071055A1 (es) | Anticuerpos anti mn | |
AR084210A1 (es) | PROTEINAS DE UNION AL TNF-a | |
BR112013008765B8 (pt) | Anticorpos monoclonais anti-tau humano isolados ou um fragmento de ligação à tau dos mesmos, métodos de preparação dos mesmos, polinucleotídeo ou polinucleotídeos, vetor ou vetores, composição, método in vitro de diagnóstico ou monitoramento da progressão de uma tauopatia neurodegenerativa em um indivíduo humano, método in vitro para diagnosticar uma tauopatia neurodegenerativa em um indivíduo humano, e kit útil para o diagnóstico de uma tauopatia neurodegenerativa | |
RU2015103228A (ru) | Антитела против тау | |
PE20220004A1 (es) | Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh | |
RU2014101707A (ru) | АНТИ-Axl АНТИТЕЛА И ИХ ПРИМЕНЕНИЕ | |
FR2933773B1 (fr) | Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal | |
WO2009019365A3 (fr) | Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal | |
RU2011121818A (ru) | Способ иммунологического анализа белка cxcl1 человека | |
NZ594682A (en) | Fully human antibodies specific to cadm1 | |
EA201590459A1 (ru) | Специфические антитела к островковому амилоидному полипептиду человека (hiapp) и их применение | |
RU2016116773A (ru) | Способ выявления опухоли поджелудочной железы, антитела и набор для выявления опухоли поджелудочной железы | |
JP2018507254A5 (es) | ||
JP2018515071A5 (es) | ||
GB0616929D0 (en) | Antibodies, assays and hybridomas | |
WO2014192974A1 (ja) | 抗lgr6抗体を含む癌の検出用又は診断用試薬 | |
WO2007008092A3 (en) | Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus | |
WO2015078711A3 (en) | Methods, peptides and antibodies for preventing, treating and diagnosing an inflammatory condition | |
JPWO2012029990A1 (ja) | 大腸がんマーカーに対する抗体 | |
AR102966A1 (es) | ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO M DEL VIRUS METAPNEUMOVIRUS HUMANO (hMPV), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR hMPV | |
MX2023004212A (es) | Conjugados reactivos. | |
MX2021007870A (es) | Anticuerpos monoclonales especificos para la proteina quimerica l del virus de la parainfluenza humana (piv), secuencias nucleotidicas; metodo y kit de diagnostico de infeccion producida por piv. |